Literature DB >> 11001547

Human gammadelta T lymphocytes exert natural and IL-2-induced cytotoxicity to neuroblastoma cells.

K E Schilbach1, A Geiselhart, J T Wessels, D Niethammer, R Handgretinger.   

Abstract

Human gammadelta T lymphocytes play an important role in nonadaptive reactions to infection and early tumor defense. This is the first report that freshly isolated, native gammadelta T cells of some healthy donors can kill human neuroblastoma cells to varying degrees. Their killing ability was increased and maintained during expansion and cultivation with interleukin-2 (IL-2; 400 IU/mL) for as long as 30 days (100% specific lysis at an effector-to-target cell (E:T) ratio of 20:1). gammadelta T lymphocytes without this spontaneous killing ability gained a specific cytolytic activity of 81% +/- 10.4% SD after stimulation with IL-2 for 24 hours. gammadelta cells were isolated from peripheral blood by positive enrichment (using a magnetic cell sorting system; purity, 95.2% +/- 3.2% SD, n = 21). High natural cytotoxic activity against human neuroblastoma cell lines (>50% specific lysis at an E:T ratio of 20:1) was exhibited by one of 11 donors, whereas two of 11 showed medium cytotoxicity (30% to 50% specific lysis). Eight of 11 donors showed very slight or no lytic activity against human neuroblastoma cells (<30% specific lysis). gammadelta T cells were also cytotoxic against Daudi (32.7% specific lysis at an E:T ratio of 20:1), Raji (10.3%), Colo 205 (23.1%), A 204 (54%), K 562 (100%), and SK-N-MC (100%) cells. Isolated gammadelta T cells were grown in Iscove modified Dulbecco medium with IL-2 (400 IU/mL). Increased cell proliferation (38.5% to 182%) was induced with phytohemagglutinin, IL-15, Clodronat, OKT3, or various combinations of these. Results of cold target inhibition assays suggest a natural killer-like activity of the gammadelta T-cell killing mechanism. Peptidase or papain render neuroblastoma cells unsusceptible to gammadelta T-cell killing, suggesting the involvement of antigen peptide(s) in the process of neuroblastoma cell killing. Treatment with acid phosphatase reduced specific lysis by 66.5% +/- 34.1% SD, which suggests a binding to phosphorylated neuroblastoma cell-surface structures in the killing mechanism of gammadelta T cells. Heat shock did not affect the extent of neuroblastoma killing by gammadelta cells. Recognition of neuroblastoma cells by gammadelta cytotoxic T lymphocytes is negatively regulated by major histocompatibility complex I receptors. Evidence for natural and inducible cell cytotoxicity of gammadelta T cells against human neuroblastoma cells, easy propagation, purification, and missing alloreactivity in mixed lymphocytes cultures indicates a role for this subpopulation of T lymphocytes in adoptive immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11001547     DOI: 10.1097/00002371-200009000-00004

Source DB:  PubMed          Journal:  J Immunother        ISSN: 1524-9557            Impact factor:   4.456


  15 in total

Review 1.  Gammadelta T cells as immune effectors against high-grade gliomas.

Authors:  Lawrence S Lamb
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

2.  miR-125b-5p and miR-99a-5p downregulate human γδ T-cell activation and cytotoxicity.

Authors:  Yuli Zhu; Siya Zhang; Zinan Li; Huaishan Wang; Zhen Li; Yu Hu; Hui Chen; Xuan Zhang; Lianxian Cui; Jianmin Zhang; Wei He
Journal:  Cell Mol Immunol       Date:  2018-02-12       Impact factor: 11.530

3.  Mechanisms of the antitumor activity of human Vγ9Vδ2 T cells in combination with zoledronic acid in a preclinical model of neuroblastoma.

Authors:  Emma Di Carlo; Paola Bocca; Laura Emionite; Michele Cilli; Giuseppe Cipollone; Fabio Morandi; Lizzia Raffaghello; Vito Pistoia; Ignazia Prigione
Journal:  Mol Ther       Date:  2013-03-12       Impact factor: 11.454

4.  Phenotypic and functional alterations of Vgamma2Vdelta2 T cell subsets in patients with active nasopharyngeal carcinoma.

Authors:  Kia Joo Puan; John Seng Hooi Low; Terence Wee Kiat Tan; Joseph Tien Seng Wee; Eng Huat Tan; Kam Weng Fong; Eu Tiong Chua; Chenggang Jin; José-Luis Giner; Craig T Morita; Christopher Hood Keng Goh; Kam M Hui
Journal:  Cancer Immunol Immunother       Date:  2008-11-30       Impact factor: 6.968

Review 5.  Cytotoxic and regulatory properties of circulating Vδ1+ γδ T cells: a new player on the cell therapy field?

Authors:  Gabrielle M Siegers; Lawrence S Lamb
Journal:  Mol Ther       Date:  2014-06-04       Impact factor: 11.454

6.  Cerebrospinal fluid γδ T cell frequency is age-related: a case-control study of 435 children with inflammatory and non-inflammatory neurological disorders.

Authors:  M R Pranzatelli; T J Allison; N R McGee; E D Tate
Journal:  Clin Exp Immunol       Date:  2018-03-24       Impact factor: 4.330

Review 7.  Emerging Concepts of Tissue-resident Memory T Cells in Transplantation.

Authors:  Jianing Fu; Megan Sykes
Journal:  Transplantation       Date:  2022-11-24       Impact factor: 5.385

8.  CMV-independent lysis of glioblastoma by ex vivo expanded/activated Vδ1+ γδ T cells.

Authors:  Andrea Knight; Hilal Arnouk; William Britt; G Yancey Gillespie; Gretchen A Cloud; Lualhati Harkins; Yun Su; Mark W Lowdell; Lawrence S Lamb
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240

Review 9.  Recent developments in cell-based immune therapy for neuroblastoma.

Authors:  Michael R Verneris; John E Wagner
Journal:  J Neuroimmune Pharmacol       Date:  2007-03-02       Impact factor: 7.285

Review 10.  γδ T cells and their potential for immunotherapy.

Authors:  Yan-Ling Wu; Yan-Ping Ding; Yoshimasa Tanaka; Li-Wen Shen; Chuan-He Wei; Nagahiro Minato; Wen Zhang
Journal:  Int J Biol Sci       Date:  2014-01-10       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.